<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Large-scale integrated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> genome characterization efforts including the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> genome atlas and the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell line encyclopedia have created unprecedented opportunities to study <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> biology in the context of knowing the entire catalog of genetic alterations </plain></SENT>
<SENT sid="1" pm="."><plain>A clinically important challenge is to discover <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> subtypes and their molecular drivers in a comprehensive genetic context </plain></SENT>
<SENT sid="2" pm="."><plain>Curtis et al </plain></SENT>
<SENT sid="3" pm="."><plain>[Nature (2012) 486(7403):346-352] has recently shown that integrative clustering of copy number and gene expression in 2,000 breast <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> reveals novel subgroups beyond the classic expression subtypes that show distinct clinical outcomes </plain></SENT>
<SENT sid="4" pm="."><plain>To extend the scope of integrative analysis for the inclusion of <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> data by massively parallel sequencing, we propose a framework for joint modeling of discrete and continuous variables that arise from integrated genomic, epigenomic, and transcriptomic profiling </plain></SENT>
<SENT sid="5" pm="."><plain>The core idea is motivated by the hypothesis that diverse molecular phenotypes can be predicted by a set of orthogonal latent variables that represent distinct molecular drivers, and thus can reveal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> subgroups of biological and clinical importance </plain></SENT>
<SENT sid="6" pm="."><plain>Using the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell line encyclopedia dataset, we demonstrate our method can accurately group cell lines by their cell-of-origin for several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types, and precisely pinpoint their known and potential <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> driver genes </plain></SENT>
<SENT sid="7" pm="."><plain>Our integrative analysis also demonstrates the power for revealing subgroups that are not lineage-dependent, but consist of different <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types driven by a common genetic alteration </plain></SENT>
<SENT sid="8" pm="."><plain>Application of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> genome atlas <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> data reveals distinct integrated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> subtypes, suggesting different genetic pathways in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> progression </plain></SENT>
</text></document>